While Bolsonaro defends hydroxychloroquine, ministry reinforces need for prescription drugs

While Bolsonaro defends hydroxychloroquine, ministry reinforces need for prescription drugs

© Reuters / Ueslei Marcelino

BRASÍLIA (Reuters) – The Ministry of Health reinforced this Thursday, in a press conference on data on the situation of Covid-19 in the country, the orientation for the use of any medication to occur under medical prescription.

The executive secretary of the portfolio, Elcio Franco reinforced the recommendation “that any drug should be administered by prescription” and stated that there is still no guidance from the agency on the preventive use of substances against the coronavirus.

He considered, however, that there was evidence of cases in which the use of medicines was effective as a prevention, but he went on to say that it is up to doctors to prescribe any medication.

On Monday, even before the result of his examination, President Jair Bolsonaro said he had started using hydroxychloroquine as a way to treat Covid-19. The next day, after announcing that he had the disease, he published a video taking a pill of the medicine and stating “I trust hydroxychloroquine”.

At this Thursday’s press conference, the secretary of Science, Technology, Innovation and Strategic Inputs, Hélio Angotti, pointed out indications that the early use of chloroquine and similar medications may have contributed to the reduction of serious cases, but considered that the production of scientific evidence may lead “years” to consolidate.

Asked about the cardiac risks of using the medication, Neto said that “there is practically no” risk of severe arrhythmia in patients who do not have heart problems and are in the early stages of the disease.

The folder technicians were questioned about the fact that Bolsonaro, affected by the new virus, uses hydroxychloroquine and has his heart system monitored more than once daily, limiting himself to saying, referring to generic cases, that ” it is up to the doctor who performed the prescription to decide on the best laboratory follow-up scheme or by means of other complementary tests “.

(Reporting by Maria Carolina Marcello)


Please enter your comment!
Please enter your name here